Cvs Health (CVS) Receivables - Other (2017 - 2026)

Cvs Health's Receivables - Other history runs 10 years deep, the most recent figure standing at $12.5 billion for Q1 2026.

• Quarterly Receivables - Other rose 19.72% year-over-year to $12.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 billion (up 19.72% YoY) and the FY2025 annual result came in at $7.9 billion, down 20.06% from the prior year.
• Receivables - Other was $12.5 billion for Q1 2026 at Cvs Health, up from $7.9 billion in the prior quarter.
• Across five years, Receivables - Other topped out at $12.5 billion in Q1 2026 and bottomed at $7.9 billion in Q4 2025.
• A 5-year average of $9.9 billion and a median of $9.9 billion in 2024 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2023 — Receivables - Other surged 32.56% — and 2025, when it dropped 20.06%.
• Cvs Health's Receivables - Other stood at $9.0 billion in 2022, then jumped by 32.56% to $11.9 billion in 2023, then decreased by 17.02% to $9.9 billion in 2024, then dropped by 20.06% to $7.9 billion in 2025, then jumped by 58.39% to $12.5 billion in 2026.
• Business Quant data shows CVS's Receivables - Other at $12.5 billion in Q1 2026, $7.9 billion in Q4 2025, and $11.2 billion in Q3 2025.